Cargando…

A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro

Pancreatic cancer exhibits a worst prognosis owed to an aggressive tumor progression i.a. driven by chemoresistance or tumor‐stroma‐interactions. The identification of candidate genes, which promote this progression, can lead to new therapeutic targets and might improve patient's outcome. The i...

Descripción completa

Detalles Bibliográficos
Autores principales: Widder, Miriam, Lemke, Karen, Kekeç, Bünyamin, Förster, Tobias, Grodrian, Andreas, Gastrock, Gunter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873453/
https://www.ncbi.nlm.nih.gov/pubmed/29610566
http://dx.doi.org/10.1002/elsc.201700008
_version_ 1783310041932103680
author Widder, Miriam
Lemke, Karen
Kekeç, Bünyamin
Förster, Tobias
Grodrian, Andreas
Gastrock, Gunter
author_facet Widder, Miriam
Lemke, Karen
Kekeç, Bünyamin
Förster, Tobias
Grodrian, Andreas
Gastrock, Gunter
author_sort Widder, Miriam
collection PubMed
description Pancreatic cancer exhibits a worst prognosis owed to an aggressive tumor progression i.a. driven by chemoresistance or tumor‐stroma‐interactions. The identification of candidate genes, which promote this progression, can lead to new therapeutic targets and might improve patient's outcome. The identification of these candidates in a plethora of genes requires suitable screening protocols. The aim of the present study was to establish a universally usable device which ensures versatile cultivation, screening and handling protocols of cancer cells with the 3D spheroid model, an approved model to study tumor biology. By surface modification and alternative handling of a commercial 384‐well plate, a modified device enabling (i) 3D cultivation either by liquid overlay or by a modified hanging drop method for (ii) screening of substances as well as for tumor‐stroma‐interactions (iii) either with manual or automated handling was established. The here presented preliminary results of cell line dependent dose‐response‐relations and a stromal‐induced spheroid‐formation of the pancreatic cancer cells demonstrate the proof‐of‐principle of the versatile functionality of this device. By adapting the protocols to automation, a higher reproducibility and the ability for high‐throughput analyses were ensured.
format Online
Article
Text
id pubmed-5873453
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58734532018-03-31 A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro Widder, Miriam Lemke, Karen Kekeç, Bünyamin Förster, Tobias Grodrian, Andreas Gastrock, Gunter Eng Life Sci Technical Report Pancreatic cancer exhibits a worst prognosis owed to an aggressive tumor progression i.a. driven by chemoresistance or tumor‐stroma‐interactions. The identification of candidate genes, which promote this progression, can lead to new therapeutic targets and might improve patient's outcome. The identification of these candidates in a plethora of genes requires suitable screening protocols. The aim of the present study was to establish a universally usable device which ensures versatile cultivation, screening and handling protocols of cancer cells with the 3D spheroid model, an approved model to study tumor biology. By surface modification and alternative handling of a commercial 384‐well plate, a modified device enabling (i) 3D cultivation either by liquid overlay or by a modified hanging drop method for (ii) screening of substances as well as for tumor‐stroma‐interactions (iii) either with manual or automated handling was established. The here presented preliminary results of cell line dependent dose‐response‐relations and a stromal‐induced spheroid‐formation of the pancreatic cancer cells demonstrate the proof‐of‐principle of the versatile functionality of this device. By adapting the protocols to automation, a higher reproducibility and the ability for high‐throughput analyses were ensured. John Wiley and Sons Inc. 2017-11-24 /pmc/articles/PMC5873453/ /pubmed/29610566 http://dx.doi.org/10.1002/elsc.201700008 Text en © 2017 The Authors. Engineering in Life Sciences published by Wiley‐VCH Verlag GmbH & Co. KGaA This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Report
Widder, Miriam
Lemke, Karen
Kekeç, Bünyamin
Förster, Tobias
Grodrian, Andreas
Gastrock, Gunter
A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
title A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
title_full A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
title_fullStr A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
title_full_unstemmed A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
title_short A modified 384‐well‐device for versatile use in 3D cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
title_sort modified 384‐well‐device for versatile use in 3d cancer cell (co‐)cultivation and screening for investigations of tumor biology in vitro
topic Technical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873453/
https://www.ncbi.nlm.nih.gov/pubmed/29610566
http://dx.doi.org/10.1002/elsc.201700008
work_keys_str_mv AT widdermiriam amodified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT lemkekaren amodified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT kekecbunyamin amodified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT forstertobias amodified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT grodrianandreas amodified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT gastrockgunter amodified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT widdermiriam modified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT lemkekaren modified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT kekecbunyamin modified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT forstertobias modified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT grodrianandreas modified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro
AT gastrockgunter modified384welldeviceforversatileusein3dcancercellcocultivationandscreeningforinvestigationsoftumorbiologyinvitro